• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Larimar Therapeutics, Inc. - Common Stock (NQ:LRMR)

5.220 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Mar 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,851,822
Open 5.080
Bid (Size) 5.320 (100)
Ask (Size) 5.380 (100)
Prev. Close 5.220
Today's Range 4.940 - 5.260
52wk Range 1.610 - 6.420
Shares Outstanding 43,269,200
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Unusual volume stocks are being observed in Thursday's session. ↗
February 26, 2026
Via Chartmill
News headline image
Stocks Under $5 to Watch Now: LRMR, RXRX, NDRA, BTQ, CDIO Watch Now!
February 26, 2026
Via AB Newswire
Topics Artificial Intelligence Intellectual Property

Performance

YTD
+50.4%
+50.4%
1 Month
+70.0%
+70.0%
3 Month
+36.6%
+36.6%
6 Month
+32.8%
+32.8%
1 Year
+72.3%
+72.3%

More News

Read More
News headline image
Nasdaq, S&P 500 Futures Tread Caution On Nvidia’s China Risk: Why NFLX, WBD, AAPL, CRM, AI, LRMR Are On Traders' Radar Today ↗
February 26, 2026
Via Stocktwits
Topics Artificial Intelligence ETFs Stocks
News headline image
Larimar Prices $100M Stock Sale After Record Rally Fueled By FDA Breakthrough Tag For Protein Replacement Therapy ↗
February 25, 2026
Via Stocktwits
Let's take a look at the stocks that are in motion in today's session. ↗
February 25, 2026
Via Chartmill
News headline image
Laminar Therapeutics Stock Is Popping Today: What's Going On? ↗
February 25, 2026
Via Benzinga
These stocks are the most active in today's session ↗
February 25, 2026
Via Chartmill
The trading volume of these stocks is deviating from the norm in today's session. ↗
February 25, 2026
Via Chartmill
Here are the top movers in Wednesday's session. ↗
February 25, 2026
Via Chartmill
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
February 24, 2026
Via Chartmill
Curious about the most active stocks on Tuesday? ↗
February 24, 2026
Via Chartmill
Tuesday's session: top gainers and losers ↗
February 24, 2026
Via Chartmill
News headline image
Larimar Therapeutics (LRMR) Surges On FDA Breakthrough Therapy Designation ↗
February 24, 2026
Via Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
February 24, 2026
Via Chartmill
News headline image
Why Did Larimar Therapeutics’ Stock Surge Over 30% Pre-Market Today? ↗
February 24, 2026
Via Stocktwits
Which stocks are moving before the opening bell on Tuesday? ↗
February 24, 2026
Via Chartmill
News headline image
What's going on in today's after hours session ↗
November 17, 2025
Via Chartmill
News headline image
Rosen Law Firm Encourages Larimar Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – LRMR
October 30, 2025
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
LRMR Investors Have Opportunity to Join Larimar Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
October 29, 2025
From Schall Law
Via GlobeNewswire
News headline image
The Best AI for Picking Stocks, Ranked by Performance ↗
October 22, 2025
Via MarketBeat
Topics Artificial Intelligence ETFs
News headline image
Rosen Law Firm Encourages Larimar Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – LRMR
October 22, 2025
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
Larimar Therapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – LRMR
October 15, 2025
From DJS Law Group
Via Business Wire
News headline image
LRMR Investors Have Opportunity to Join Larimar Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
October 15, 2025
From The Schall Law Firm
Via Business Wire
News headline image
Quantum Computing, Mesoblast And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
October 06, 2025
Via Benzinga
News headline image
Which stocks are moving on Wednesday? ↗
October 01, 2025
Via Chartmill

Frequently Asked Questions

Is Larimar Therapeutics, Inc. - Common Stock publicly traded?
Yes, Larimar Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Larimar Therapeutics, Inc. - Common Stock trade on?
Larimar Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Larimar Therapeutics, Inc. - Common Stock?
The ticker symbol for Larimar Therapeutics, Inc. - Common Stock is LRMR on the Nasdaq Stock Market
What is the current price of Larimar Therapeutics, Inc. - Common Stock?
The current price of Larimar Therapeutics, Inc. - Common Stock is 5.220
When was Larimar Therapeutics, Inc. - Common Stock last traded?
The last trade of Larimar Therapeutics, Inc. - Common Stock was at 03/06/26 04:00 PM ET
What is the market capitalization of Larimar Therapeutics, Inc. - Common Stock?
The market capitalization of Larimar Therapeutics, Inc. - Common Stock is 225.87M
How many shares of Larimar Therapeutics, Inc. - Common Stock are outstanding?
Larimar Therapeutics, Inc. - Common Stock has 226M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap